Keflex

Compliance

Poor compliance was cited by physicians as the #1 reason why patients fail oral antibiotic therapy.³ Reduced daily dosing frequency makes dosing easier and can potentially help improve patient compliance.^4-7

Patient non-compliance to antibiotics can have profound implications and can lead to⁶:

Ineffective management
Deterioration of patients' health
Hospital admissions
Additional costs
Emergence of antibiotic-resistant microorganisms

Skipping doses or not completing the full course of therapy may decrease the effectiveness of the treatment and increase the likelihood that bacteria will develop resistance in the future and will not be treatable by Keflex^® or other antibacterial drugs.²

Just Two Steps

Just two steps to achieve the 1500 mg total daily dose with Keflex 750 mg BID

KEFLEX is indicated for the treatment of respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections in adults and children six months and older.

Important Safety Information
KEFLEX is contraindicated in patients with known allergy to the cephalosporin group of antibiotics. Before therapy with cephalexin is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalexin, cephalosporins, penicillins, or other drugs. KEFLEX should be administered with caution in the presence of markedly impaired renal function or a history of gastrointestinal disease, particularly Clostridium difficile associated diarrhea (CDAD).

904-0606-0017r

MiddleBrook Pharmaceuticals, Inc.